ACARE has identified the need for the development and implementation of teaching and training formats for health care professionals, scientists and other members of pharmaceutical organisations focused on recurrent angioedema. Given the rapid development of our understanding of these diseases, fellows involved in the development of new treatment options need to be up to date on the latest therapies and emerging targets for novel and better treatment options. Currently, there is only a limited number of teaching and training programs on recurrent angioedema that address this need.
To change this, we have developed a series of regional specific preceptorships on recurrent angioedema that have taken place in Japan, China and Oman with more planned. Due to the pandemic causing these in person events to cease, we put the program forward in the form of a digital program called INTERACT. Digital events have shown their value, but we see the need to have these preceptorships face to face again. The two-day program on the pathogenesis, differential diagnosis, burden and impact, prevalence, diagnostic work up, PROMs and management of recurrent angioedema are catered towards the need of fellows involved in the development of new treatment options and their positioning in clinical practice.
We have found that there is a need for preceptorships in subcontinental Asia, the Arabian gulf, and other Growth & Emerging Markets. The first proposed preceptorship would be held in Chandigar, India at the Advanced Pediatrics centre, Postgraduate Institute of Medical Education and Research. The preceptorship will be held with the help of Dr. Ankur Jindal and his colleagues from this hospital.
See here for more information.